134 related articles for article (PubMed ID: 34526229)
1. Sarcopenia predicts reduced liver growth and reduced resectability in patients undergoing portal vein embolization before liver resection - A DRAGON collaborative analysis of 306 patients.
Heil J; Heid F; Bechstein WO; Björnsson B; Brismar TB; Carling U; Erdmann J; Fretland ÅA; Grunhagen D; Hana RA; Hohmann J; Linke R; Meyer Y; Nawawi A; Olthof PB; Sandström P; Schnitzbauer AA; Sparrelid E; Verhoef C; Metrakos P; Schadde E
HPB (Oxford); 2022 Mar; 24(3):413-421. PubMed ID: 34526229
[TBL] [Abstract][Full Text] [Related]
2. Overall Body Composition and Sarcopenia Are Associated with Poor Liver Hypertrophy Following Portal Vein Embolization.
Denbo JW; Kim BJ; Vauthey JN; Tzeng CW; Ma J; Huang SY; Chun YS; Katz MHG; Aloia TA
J Gastrointest Surg; 2021 Feb; 25(2):405-410. PubMed ID: 31997073
[TBL] [Abstract][Full Text] [Related]
3. Effect of Sarcopenia on the Increase in Liver Volume and Function After Portal Vein Embolization.
Arntz PJW; Olthof PB; Korenblik R; Heil J; Kazemier G; van Delden OM; Bennink RJ; Damink SWMO; van Dam RM; Schadde E; Erdmann JI
Cardiovasc Intervent Radiol; 2024 May; 47(5):642-649. PubMed ID: 38416177
[TBL] [Abstract][Full Text] [Related]
4. Is the liver kinetic growth rate in ALPPS unprecedented when compared with PVE and living donor liver transplant? A multicentre analysis.
Croome KP; Hernandez-Alejandro R; Parker M; Heimbach J; Rosen C; Nagorney DM
HPB (Oxford); 2015 Jun; 17(6):477-84. PubMed ID: 25728543
[TBL] [Abstract][Full Text] [Related]
5. Preoperative portal vein or portal and hepatic vein embolization: DRAGON collaborative group analysis.
Heil J; Korenblik R; Heid F; Bechstein WO; Bemelmans M; Binkert C; Björnsson B; Breitenstein S; Detry O; Dili A; Dondelinger RF; Gerard L; Giménez-Maurel T; Guiu B; Heise D; Hertl M; Kalil JA; Klein JJ; Lakoma A; Neumann UP; Olij B; Pappas SG; Sandström P; Schnitzbauer A; Serrablo A; Tasse J; Van der Leij C; Metrakos P; Van Dam R; Schadde E
Br J Surg; 2021 Jul; 108(7):834-842. PubMed ID: 33661306
[TBL] [Abstract][Full Text] [Related]
6. Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant.
Shindoh J; Truty MJ; Aloia TA; Curley SA; Zimmitti G; Huang SY; Mahvash A; Gupta S; Wallace MJ; Vauthey JN
J Am Coll Surg; 2013 Feb; 216(2):201-9. PubMed ID: 23219349
[TBL] [Abstract][Full Text] [Related]
7. Influence of cholestasis on portal vein embolization-induced hypertrophy of the future liver remnant.
Chang X; Korenblik R; Olij B; Knapen RRMM; van der Leij C; Heise D; den Dulk M; Neumann UP; Schaap FG; van Dam RM; Olde Damink SWM
Langenbecks Arch Surg; 2023 Jan; 408(1):54. PubMed ID: 36680689
[TBL] [Abstract][Full Text] [Related]
8. Radiological Simultaneous Portohepatic Vein Embolization (RASPE) Before Major Hepatectomy: A Better Way to Optimize Liver Hypertrophy Compared to Portal Vein Embolization.
Laurent C; Fernandez B; Marichez A; Adam JP; Papadopoulos P; Lapuyade B; Chiche L
Ann Surg; 2020 Aug; 272(2):199-205. PubMed ID: 32675481
[TBL] [Abstract][Full Text] [Related]
9. Salvage parenchymal liver transection for patients with insufficient volume increase after portal vein occlusion -- an extension of the ALPPS approach.
Tschuor Ch; Croome KP; Sergeant G; Cano V; Schadde E; Ardiles V; Slankamenac K; Clariá RS; de Santibaňes E; Hernandez-Alejandro R; Clavien PA
Eur J Surg Oncol; 2013 Nov; 39(11):1230-5. PubMed ID: 23994139
[TBL] [Abstract][Full Text] [Related]
10. Correlation Between Sarcopenia and Growth Rate of the Future Liver Remnant After Portal Vein Embolization in Patients with Colorectal Liver Metastases.
Schulze-Hagen M; Truhn D; Duong F; Keil S; Pedersoli F; Kuhl CK; Lurje G; Neumann U; Isfort P; Bruners P; Zimmermann M
Cardiovasc Intervent Radiol; 2020 Jun; 43(6):875-881. PubMed ID: 31974746
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing hypertrophy of the left lateral liver lobe after portal vein embolization.
Malinowski M; Stary V; Lock JF; Schulz A; Jara M; Seehofer D; Gebauer B; Denecke T; Geisel D; Neuhaus P; Stockmann M
Langenbecks Arch Surg; 2015 Feb; 400(2):237-46. PubMed ID: 25559774
[TBL] [Abstract][Full Text] [Related]
12. Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils.
Madoff DC; Abdalla EK; Gupta S; Wu TT; Morris JS; Denys A; Wallace MJ; Morello FA; Ahrar K; Murthy R; Lunagomez S; Hicks ME; Vauthey JN
J Vasc Interv Radiol; 2005 Feb; 16(2 Pt 1):215-25. PubMed ID: 15713922
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous radiofrequency-assisted liver partition versus portal vein embolization before hepatectomy for perihilar cholangiocarcinoma.
Melekhina O; Efanov M; Alikhanov R; Tsvirkun V; Kulezneva Y; Kazakov I; Vankovich A; Koroleva A; Khatkov I
BJS Open; 2020 Feb; 4(1):101-108. PubMed ID: 32011818
[TBL] [Abstract][Full Text] [Related]
14. Gd-EOB-DTPA-enhanced MRI for monitoring future liver remnant function after portal vein embolization and extended hemihepatectomy: A prospective trial.
Geisel D; Raabe P; Lüdemann L; Malinowski M; Stockmann M; Seehofer D; Pratschke J; Hamm B; Denecke T
Eur Radiol; 2017 Jul; 27(7):3080-3087. PubMed ID: 27966044
[TBL] [Abstract][Full Text] [Related]
15. Combined biembolization induces higher hypertrophy than portal vein embolization before major liver resection.
Le Roy B; Gallon A; Cauchy F; Pereira B; Gagnière J; Lambert C; Yoh T; Boyer L; Pezet D; Buc E; Chabrot P
HPB (Oxford); 2020 Feb; 22(2):298-305. PubMed ID: 31481315
[TBL] [Abstract][Full Text] [Related]
16. Significance of Skeletal Muscle Loss in Liver Hypertrophy in Patients Undergoing Portal Vein Embolization Before Major Hepatectomy: Assessment With Body Composition and Nutritional Indicators.
Araki K; Harimoto N; Shibuya K; Watanabe A; Tsukagoshi M; Ishii N; Hagiwara K; Muranushi R; Hoshino K; Seki T; Shirabe K
Anticancer Res; 2023 Jan; 43(1):209-216. PubMed ID: 36585158
[TBL] [Abstract][Full Text] [Related]
17. Hepatic vein embolization after portal vein embolization to induce additional liver hypertrophy in patients with metastatic colorectal carcinoma.
Niekamp AS; Huang SY; Mahvash A; Odisio BC; Ahrar K; Tzeng CD; Vauthey JN
Eur Radiol; 2020 Jul; 30(7):3862-3868. PubMed ID: 32144462
[TBL] [Abstract][Full Text] [Related]
18. Liver regeneration after portal and hepatic vein embolization improves overall survival compared with portal vein embolization alone: mid-term survival analysis of the multicentre DRAGON 0 cohort.
Korenblik R; Heil J; Smits J; James S; Olij B; Bechstein WO; Bemelmans MHA; Binkert CA; Breitenstein S; Williams M; Detry O; Dewulf MJL; Dili A; Grochola LF; Grote J; Heise D; Kalil JA; Metrakos P; Neumann UP; Pappas SG; Pennetta F; Schnitzbauer AA; Tasse JC; Winkens B; Olde Damink SWM; van der Leij C; Schadde E; van Dam RM;
Br J Surg; 2024 Apr; 111(4):. PubMed ID: 38662462
[TBL] [Abstract][Full Text] [Related]
19. Portal Vein Embolization Using N-Butyl Cyanoacrylate-Glue: What Impact Does a Central Vascular Plug Have?
Carling U; Røsok B; Berger S; Fretland ÅA; Dorenberg E
Cardiovasc Intervent Radiol; 2022 Apr; 45(4):450-458. PubMed ID: 34907454
[TBL] [Abstract][Full Text] [Related]
20. Preoperative portal vein embolization for major liver resection: a meta-analysis.
Abulkhir A; Limongelli P; Healey AJ; Damrah O; Tait P; Jackson J; Habib N; Jiao LR
Ann Surg; 2008 Jan; 247(1):49-57. PubMed ID: 18156923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
